Advent Access

Advent Access

Unlocking the Future of Dialysis

Founded 2015

Singapore 1 employees Seed Total: $2.60M Health Care, Medical Devices

Advent Access is a medical technology startup based in Singapore that is dedicated to revolutionizing end-stage renal disease management. The company's flagship product, the av-Guardian™, is an innovative implant technology designed to enhance vascular access reliability for dialysis patients. This technology not only aims to reduce dialysis costs but also to improve the overall quality of life for individuals suffering from kidney failure. Additionally, the av-Guardian™ facilitates less painful self-cannulation, potentially lowering vascular access-related hospitalizations. Founded in 2015, Advent Access has garnered significant attention within the industry. It has already secured over $5.6M in private investments and research grants. In December 2017, the company closed a SGD2.60M Seed Round investment, with Advanced Medtech participating as the primary investor. It is worth noting that the company's management team and investors collectively possess extensive experience, having pioneered over ten startups in the medtech sector, along with a track record of successful IPOs and exits. Advent Access's commitment to empowering dialysis patients aligns with the growing trend towards personalized and accessible healthcare. By offering a dialysis-machine agnostic platform, the company aims to enable patients to conduct hemodialysis independently and affordably, whether at home or in alternative care environments. As a Stanford StartX company and a spin-off from A*STAR, Advent Access is well-positioned to drive significant advancements in renal care, fulfilling its slogan of "Unlocking the Future of Dialysis." For further details, visit www.adventaccess.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	SGD2.60M	1	Advanced Medtech	12 Dec 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

SGD2.60M

Advanced Medtech

12 Dec 2017

FAQ About Advent Access

Unlocking the Future of Dialysis

Advent Access was founded in 2015.

Advent Access is headquartered in Singapore.

Advent Access operates in Health Care and Medical Devices. Its work centres on Medical Technology, End-Stage Renal Disease, Dialysis Management and Vascular Access.

Advent Access has approximately 1 employees.

Advent Access has completed 1 funding round, raising a total of $2.60M. The latest funding stage is Seed.

Top alternatives and competitors to Advent Access include Access for Life, Byonyks, InnAVasc Medical, Inc., EXORENAL, Diality. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Advent Access and Access for Life are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Advent Access

Funding Rounds & Investors (1)

Advent Access Alternatives & Competitors

FAQ About Advent Access